EVEREST ORGANICS
Back to Income Statement
|
EVEREST ORGANICS Last 5 Year Operating Profit History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹20 Cr | ₹7.19 Cr | ₹11 Cr | ₹0.93 Cr | ₹6.43 Cr |
What is the latest Operating Profit of EVEREST ORGANICS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹20 Cr |
| Mar2025 | ₹7.19 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹0.93 Cr |
| Mar2022 | ₹6.43 Cr |
How is Operating Profit of EVEREST ORGANICS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹20 Cr | 175.54 | |
| Mar2025 | ₹7.19 Cr | -34.56 | |
| Mar2024 | ₹11 Cr | 1,081.40 | |
| Mar2023 | ₹0.93 Cr | -85.53 | |
| Mar2022 | ₹6.43 Cr | - | |
Compare Operating Profit of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹239.0 Cr | 1.7% | -1.2% | -39.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 1.7% |
-1.2% |
-39.1% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses